Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CDK1 | P06493 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5703485 | 0.99 | GAA (0.58) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL6906447 | 0.98 | GAA (0.60) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL10455437 | 0.93 | ALDH1A1 (0.54) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL10455589 | 0.91 | GAA (0.53) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL11190999 | 0.88 | GAA (0.56) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL10761368 | 0.88 | GAA (0.56) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL10728126 | 0.87 | GAA (0.55) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL10968869 | 0.86 | GAA (0.54) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL10616134 | 0.86 | GAA (0.67) | GAAALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL11160142 | 0.85 | GAA (0.53) | GAAALDH1A1KDM4ENPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6743754-B2 | A SULFONYLUREA AND ONE OR MORE SURFACTANTS COMPRISING AS STRUCTURAL ELEMENT AT LEAST 10 ALKYLENE OXIDE UNITS. | AVENTIS CROPSCIENCE GMBH (DE) | 2004-06-01 | — | — | US | disclosed |
| US-20020091066-A1 | Herbicidal compositions | BAYER CROPSCIENCE GMBH (DE) | 2002-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091066-A1 | Herbicidal compositions | CBR1, CBR3, GLRA1 | GAA 1644/4885ALDH1A1 323/4885KDM4E 3026/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.